Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
University of Virginia
Research
Novartis' MS drug Gilenya could inspire new CKD treatment
Scientists at the University of Virginia found that targeting a cellular transporter of S1P might be a viable strategy for chronic kidney disease.
Angus Liu
Aug 18, 2022 4:55pm
A drug may already exist to counter heart risk in older men
Jul 14, 2022 2:00pm
Rivus' fat-trimming therapy nabs $35M for a host of diseases
Jul 20, 2021 9:08am
Fending off heart attacks by getting at their genetic roots
Dec 11, 2020 7:55am
Diffusion CSO and co-founder Gainer set to resign next month
Feb 7, 2020 8:20am
Brain’s lymphatic system linked to aging and Alzheimer’s
Jul 27, 2018 11:20am
